The current study, as an extension of Cao et al.’s research, demonstrated for the first time the potential utility of the ALT/HDL-C ratio in identifying NAFLD (AUC=0.8553). The gene discussed is GPT; the disease is metabolic dysfunction-associated steatotic liver disease.